An amount held back or not released; in reinsurance, it is the proportion of the line written by the original Insurer that is not ceded to the reinsurer.
This entry was posted in . Bookmark the permalink.
A “twin” to a “brand name drug” once the brand name company’s patent has run out and other drug companies are allowed to sell a duplicate of the original. Generic drugs are cheaper, and most prescription and health plans reward clients for choosing generics.